A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.
Research output: Contribution to journal › Article
A statistical model based on four kallikrein markers (total prostate-specific antigen [tPSA], free PSA [fPSA], intact PSA, and human kallikrein-related peptidase 2) in blood can predict risk of Gleason score ≥7 (high-grade) cancer at prostate biopsy.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Early online date||2015 May 12|
|Publication status||Published - 2015|